{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:21:47Z","timestamp":1791598907753,"version":"4.3.4"},"reference-count":155,"publisher":"Portland Press Ltd.","issue":"03","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,30]]},"abstract":"<jats:p>Approximately 35 in 100,000 people are affected by diseases associated with loss of myelin, generally described as demyelinating diseases. Demyelinating diseases encompass many different pathological conditions characterized by heterogeneous and sometimes disease-specific etiopathological mechanisms. While several approaches aimed at ameliorating the symptoms and the progression of some of these diseases exist, the most effective cure for all demyelinating diseases would be regeneration of lost myelin. Myelin regeneration occurs spontaneously in the central nervous system in response to myelin damage but is inefficient for a variety of reasons, especially in human patients. In this review, we will discuss the contributions of different cell populations to the creation of conditions permissive for effective remyelination and to the formation of new myelin after injury. Moreover, we would like to highlight the importance of sphingolipids in the network of interactions between these cell populations. Mutations in genes encoding sphingolipid metabolic enzymes (such as GALC) represent a major risk factor for multiple sclerosis, and alterations in sphingolipid metabolism in specific cell types contribute to myelin damage. On the other hand, sphingolipid signaling, in particular through sphingosine 1 phosphate, directly affects the process of myelin regeneration, with distinct effects on different cellular populations.<\/jats:p>","DOI":"10.1042\/bst20231085","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T09:24:39Z","timestamp":1750757079000},"page":"653-669","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["How do different cell populations orchestrate myelin regeneration?"],"prefix":"10.1042","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9118-9982","authenticated-orcid":false,"given":"Sara","family":"Grassi","sequence":"first","affiliation":[{"name":"Department of Medical Biotechnology and Translational Medicine, Via Fratelli Cervi 93, 20090 Segrate (Milano),University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0252-2593","authenticated-orcid":false,"given":"Alessandro","family":"Prinetti","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology and Translational Medicine, Via Fratelli Cervi 93, 20090 Segrate (Milano),University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"2025063011311691900_BST-2023-1085C1","doi-asserted-by":"crossref","first-page":"103750","DOI":"10.1016\/j.msard.2022.103750","article-title":"Sociodemographic and clinical characteristics of people with multiple sclerosis and neuro-myelitis optica spectrum disorder in a central northern region of Chile: a prevalence study","volume":"61","author":"Henr\u00edquez","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"2025063011311691900_BST-2023-1085C2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.410330202","article-title":"Molecular dissection of the myelinated axon","volume":"33","author":"Waxman","year":"1993","journal-title":"Ann. Neurol."},{"key":"2025063011311691900_BST-2023-1085C3","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/s41593-023-01366-9","article-title":"Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease","volume":"26","author":"Sch\u00e4ffner","year":"2023","journal-title":"Nat. Neurosci."},{"key":"2025063011311691900_BST-2023-1085C4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neures.2020.12.005","article-title":"Myelin plasticity modulates neural circuitry required for learning and behavior","volume":"167","author":"Kato","year":"2021","journal-title":"Neurosci. Res."},{"key":"2025063011311691900_BST-2023-1085C5","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/j.1471-4159.1990.tb04942.x","article-title":"Lysosulfatide (sulfogalactosylsphingosine) accumulation in tissues from patients with metachromatic leukodystrophy","volume":"55","author":"Toda","year":"1990","journal-title":"J. Neurochem."},{"key":"2025063011311691900_BST-2023-1085C6","doi-asserted-by":"crossref","DOI":"10.1186\/1476-511X-10-28","article-title":"Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice","volume":"10","author":"Blomqvist","year":"2011","journal-title":"Lipids Health Dis."},{"key":"2025063011311691900_BST-2023-1085C7","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1021\/bi00467a009","article-title":"Dependence of the surface expression of the glycolipid cerebroside sulfate on its lipid environment: comparison of sphingomyelin and phosphatidylcholine","volume":"29","author":"Stewart","year":"1990","journal-title":"Biochemistry"},{"key":"2025063011311691900_BST-2023-1085C8","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.bbamem.2007.12.016","article-title":"N-palmitoyl-sulfatide participates in lateral domain formation in complex lipid bilayers","volume":"1778","author":"Bj\u00f6rkqvist","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"2025063011311691900_BST-2023-1085C9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12031-024-02206-6","article-title":"Conversion of astrocyte cell lines to oligodendrocyte progenitor cells using small molecules and transplantation to animal model of multiple sclerosis","volume":"74","author":"Sharifi-Kelishadi","year":"2024","journal-title":"J. Mol. Neurosci."},{"key":"2025063011311691900_BST-2023-1085C10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25136996","article-title":"Cellular therapy in experimental autoimmune encephalomyelitis as an adjuvant treatment to translate for multiple sclerosis","volume":"25","author":"Perussolo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"2025063011311691900_BST-2023-1085C11","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-52444-w","article-title":"CRISPR-edited human ES-derived oligodendrocyte progenitor cells improve remyelination in rodents","volume":"15","author":"Wagstaff","year":"2024","journal-title":"Nat. Commun."},{"key":"2025063011311691900_BST-2023-1085C12","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70178","article-title":"Oligodendrocyte progenitor cell transplantation reduces white matter injury in a fetal goat model","volume":"30","author":"Yue","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"2025063011311691900_BST-2023-1085C13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-27559-y","article-title":"Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia","volume":"8","author":"Zorina","year":"2018","journal-title":"Sci. Rep."},{"key":"2025063011311691900_BST-2023-1085C14","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1523\/JNEUROSCI.17-19-07267.1997","article-title":"Conduction in segmentally demyelinated mammalian central axons","volume":"17","author":"Felts","year":"1997","journal-title":"J. Neurosci."},{"key":"2025063011311691900_BST-2023-1085C15","doi-asserted-by":"crossref","first-page":"8168","DOI":"10.1073\/pnas.0402765101","article-title":"Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+\/Ca2+ exchanger","volume":"101","author":"Craner","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2025063011311691900_BST-2023-1085C16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature09614","article-title":"Myelination and support of axonal integrity by glia","volume":"468","author":"Nave","year":"2010","journal-title":"Nature"},{"key":"2025063011311691900_BST-2023-1085C17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrn2797","article-title":"Myelination and the trophic support of long axons","volume":"11","author":"Nave","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"2025063011311691900_BST-2023-1085C18","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1172\/JCI90610","article-title":"Oligodendroglia: metabolic supporters of neurons","volume":"127","author":"Philips","year":"2017","journal-title":"J. Clin. Invest."},{"key":"2025063011311691900_BST-2023-1085C19","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1523\/JNEUROSCI.23-12-04967.2003","article-title":"Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor","volume":"23","author":"Wilkins","year":"2003","journal-title":"J. Neurosci."},{"key":"2025063011311691900_BST-2023-1085C20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00415-023-11996-5","article-title":"Update on leukodystrophies and developing trials","volume":"271","author":"Ceravolo","year":"2024","journal-title":"J. Neurol."},{"key":"2025063011311691900_BST-2023-1085C21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.molmed.2024.03.005","article-title":"Pelizaeus-merzbacher disease: on the cusp of myelin medicine","volume":"30","author":"Elitt","year":"2024","journal-title":"Trends Mol. Med."},{"key":"2025063011311691900_BST-2023-1085C22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41582-020-00432-1","article-title":"Hypomyelinating leukodystrophies - unravelling myelin biology","volume":"17","author":"Wolf","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"2025063011311691900_BST-2023-1085C23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/jnc.15133","article-title":"The role of sphingolipids in myelination and myelin stability and their involvement in childhood and adult demyelinating disorders","volume":"156","author":"Giussani","year":"2021","journal-title":"J. Neurochem."},{"key":"2025063011311691900_BST-2023-1085C24","doi-asserted-by":"crossref","DOI":"10.1186\/s40001-024-01771-1","article-title":"The natural history and burden of illness of metachromatic leukodystrophy: a systematic literature review","volume":"29","author":"Chang","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"2025063011311691900_BST-2023-1085C25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/ITT.S424622","article-title":"Globoid cell leukodystrophy (Krabbe Disease): an update","volume":"12","author":"Maghazachi","year":"2023","journal-title":"Immunotargets Ther."},{"key":"2025063011311691900_BST-2023-1085C26","doi-asserted-by":"crossref","first-page":"101236","DOI":"10.1016\/j.plipres.2023.101236","article-title":"The pathophysiological role of dihydroceramide desaturase in the nervous system","volume":"91","author":"Tzou","year":"2023","journal-title":"Prog. Lipid Res."},{"key":"2025063011311691900_BST-2023-1085C27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MCD.0000000000000457","article-title":"DEGS1 -related leukodystrophy: a clinical report and review of literature","volume":"32","author":"Wong","year":"2023","journal-title":"Clin. Dysmorphol."},{"key":"2025063011311691900_BST-2023-1085C28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ene.15593","article-title":"Diagnosis and treatment of progressive multiple sclerosis: a position paper","volume":"30","author":"Pozzilli","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"2025063011311691900_BST-2023-1085C29","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS,third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Multiple Sclerosis Journal"},{"key":"2025063011311691900_BST-2023-1085C30","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"2025063011311691900_BST-2023-1085C31","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ana.24497","article-title":"Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque","volume":"78","author":"Frischer","year":"2015","journal-title":"Ann. Neurol."},{"key":"2025063011311691900_BST-2023-1085C32","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1007\/s00415-022-11072-4","article-title":"Environmental risk factors in multiple sclerosis: bridging mendelian randomization and observational studies","volume":"269","author":"Vandebergh","year":"2022","journal-title":"J. Neurol."},{"key":"2025063011311691900_BST-2023-1085C33","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028944","article-title":"Lifestyle and environmental factors in multiple sclerosis","volume":"9","author":"Alfredsson","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2025063011311691900_BST-2023-1085C34","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1474-4422(22)00255-1","article-title":"Genetics of multiple sclerosis: lessons from polygenicity","volume":"21","author":"Goris","year":"2022","journal-title":"Lancet Neurol."},{"key":"2025063011311691900_BST-2023-1085C35","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/acn3.50862","article-title":"Environmental and genetic risk factors for MS: an integrated review","volume":"6","author":"Waubant","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"2025063011311691900_BST-2023-1085C36","doi-asserted-by":"crossref","DOI":"10.1177\/26331055221117598","article-title":"High correlations among worldwide prevalences of dementias, parkinson\u2019s disease, multiple sclerosis, and motor neuron diseases indicate common causative factors","volume":"17","author":"James","year":"2022","journal-title":"Neurosci. Insights"},{"key":"2025063011311691900_BST-2023-1085C37","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/14737175.2021.1978843","article-title":"Role of environmental factors in multiple sclerosis","volume":"21","author":"Zarghami","year":"2021","journal-title":"Expert Rev. Neurother."},{"key":"2025063011311691900_BST-2023-1085C38","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility","volume":"365","author":"Patsopoulos","year":"2019","journal-title":"Science"},{"key":"2025063011311691900_BST-2023-1085C39","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1093\/brain\/awac449","article-title":"Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity","volume":"146","author":"Jokubaitis","year":"2023","journal-title":"Brain (Bacau)"},{"key":"2025063011311691900_BST-2023-1085C40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41586-023-06250-x","article-title":"Locus for severity implicates CNS resilience in progression of multiple sclerosis","volume":"619","author":"Harroud","year":"2023","journal-title":"Nature"},{"key":"2025063011311691900_BST-2023-1085C41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4103\/1673-5374.228712","article-title":"Heterozygous carriers of galactocerebrosidase mutations that cause Krabbe disease have impaired microglial function and defective repair of myelin damage","volume":"13","author":"Scott-Hewitt","year":"2018","journal-title":"Neural Regen. Res."},{"key":"2025063011311691900_BST-2023-1085C42","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/hmg\/ddx153","article-title":"Heterozygote galactocerebrosidase (GALC) mutants have reduced remyelination and impaired myelin debris clearance following demyelinating injury","volume":"26","author":"Scott-Hewitt","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"2025063011311691900_BST-2023-1085C43","doi-asserted-by":"crossref","DOI":"10.3390\/metabo14010030","article-title":"Altered sphingolipid hydrolase activities and alpha-synuclein level in late-onset schizophrenia","volume":"14","author":"Usenko","year":"2023","journal-title":"Metabolites"},{"key":"2025063011311691900_BST-2023-1085C44","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/brain\/awac413","article-title":"GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson\u2019s disease","volume":"146","author":"Senkevich","year":"2023","journal-title":"Brain (Bacau)"},{"key":"2025063011311691900_BST-2023-1085C45","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/brain\/awac002","article-title":"Prion-like \u03b1-synuclein pathology in the brain of infants with Krabbe disease","volume":"145","author":"Hatton","year":"2022","journal-title":"Brain (Bacau)"},{"key":"2025063011311691900_BST-2023-1085C46","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/YCO.0b013e32835ed6e8","article-title":"Is Alzheimer\u2019s a disease of the white matter?","volume":"26","author":"Sachdev","year":"2013","journal-title":"Curr. Opin. Psychiatry"},{"key":"2025063011311691900_BST-2023-1085C47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/jnc.15748","article-title":"Apolipoprotein E \u03b54 disrupts oligodendrocyte differentiation by interfering with astrocyte-derived lipid transport","volume":"165","author":"Mok","year":"2023","journal-title":"J. Neurochem."},{"key":"2025063011311691900_BST-2023-1085C48","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/jnen\/nlac054","article-title":"Apolipoprotein E \u03b54 Mediates Myelin Breakdown by Targeting Oligodendrocytes in Sporadic Alzheimer Disease","volume":"81","author":"Cheng","year":"2022","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2025063011311691900_BST-2023-1085C49","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb8680","article-title":"Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer\u2019s disease","volume":"6","author":"Zhang","year":"2020","journal-title":"Sci Adv"},{"key":"2025063011311691900_BST-2023-1085C50","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/alz.12310","article-title":"Alzheimer\u2019s disease alters oligodendrocytic glycolytic and ketolytic gene expression","volume":"17","author":"Saito","year":"2021","journal-title":"Alzheimers. Dement."},{"key":"2025063011311691900_BST-2023-1085C51","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s11064-017-2280-2","article-title":"Sphingosine toxicity in EAE and MS: evidence for ceramide generation via serine-palmitoyltransferase activation","volume":"42","author":"Miller","year":"2017","journal-title":"Neurochem. Res."},{"key":"2025063011311691900_BST-2023-1085C52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1750-3639.2011.00501.x","article-title":"Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury","volume":"22","author":"Kim","year":"2012","journal-title":"Brain Pathol."},{"key":"2025063011311691900_BST-2023-1085C53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s12276-024-01176-4","article-title":"Acid sphingomyelinase as a pathological and therapeutic target in neurological disorders: focus on Alzheimer\u2019s disease","volume":"56","author":"Choi","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"2025063011311691900_BST-2023-1085C54","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000484621","article-title":"Blockade of experimental multiple sclerosis by inhibition of the acid sphingomyelinase\/ceramide system","volume":"25","author":"Becker","year":"2017","journal-title":"Neurosignals"},{"key":"2025063011311691900_BST-2023-1085C55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178622","article-title":"Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination","volume":"12","author":"Chami","year":"2017","journal-title":"Plos One"},{"key":"2025063011311691900_BST-2023-1085C56","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049995","article-title":"A zebrafish model of combined saposin deficiency identifies acid sphingomyelinase as a potential therapeutic target","volume":"16","author":"Zhang","year":"2023","journal-title":"Dis. Model. Mech."},{"key":"2025063011311691900_BST-2023-1085C57","doi-asserted-by":"crossref","first-page":"20","DOI":"10.33594\/000000183","article-title":"Pharmacological inhibition of acid sphingomyelinase ameliorates experimental autoimmune encephalomyelitis","volume":"27","author":"Walter","year":"2019","journal-title":"Neurosignals"},{"key":"2025063011311691900_BST-2023-1085C58","article-title":"Astrocytic ceramide as possible indicator of neuroinflammation","volume":"16","author":"Martinez-Martinez","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"2025063011311691900_BST-2023-1085C59","doi-asserted-by":"crossref","DOI":"10.1007\/s11033-025-10252-5","article-title":"Lysophosphatidylcholine induces ceramide synthase-2 expression in primary culture model of astrocytopathy: potential therapeutic target in multiple sclerosis","volume":"52","author":"Mohapatra","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"2025063011311691900_BST-2023-1085C60","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/glia.24631","article-title":"Neuroprotective effect of neuron-specific deletion of the","volume":"73","author":"Amatruda","year":"2025","journal-title":"Glia"},{"key":"2025063011311691900_BST-2023-1085C61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2013.02.011","article-title":"Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy","volume":"328","author":"Groves","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"2025063011311691900_BST-2023-1085C62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023905","article-title":"Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions","volume":"6","author":"Fischer","year":"2011","journal-title":"Plos One"},{"key":"2025063011311691900_BST-2023-1085C63","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jns.2015.12.022","article-title":"Sphingosine 1-phosphate signaling in astrocytes: Implications for progressive multiple sclerosis","volume":"361","author":"Farez","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"2025063011311691900_BST-2023-1085C64","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nbd.2018.11.018","article-title":"Inactivation of sphingosine-1-phosphate receptor 2 (S1PR2) decreases demyelination and enhances remyelination in animal models of multiple sclerosis","volume":"124","author":"Seyedsadr","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"2025063011311691900_BST-2023-1085C65","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1007\/s00415-024-12384-3","article-title":"Management of multiple sclerosis in older adults: review of current evidence and future perspectives","volume":"271","author":"DiMauro","year":"2024","journal-title":"J. Neurol."},{"key":"2025063011311691900_BST-2023-1085C66","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1007\/s00415-024-12305-4","article-title":"Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption","volume":"271","author":"Singer","year":"2024","journal-title":"J. Neurol."},{"key":"2025063011311691900_BST-2023-1085C67","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1007\/s00415-024-12366-5","article-title":"Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis","volume":"271","author":"Hirt","year":"2024","journal-title":"J. Neurol."},{"key":"2025063011311691900_BST-2023-1085C68","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/08923973.2024.2330642","article-title":"Immunopathogenesis of multiple sclerosis: molecular and cellular mechanisms and new immunotherapeutic approaches","volume":"46","author":"Aliyu","year":"2024","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"2025063011311691900_BST-2023-1085C69","article-title":"Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis","volume":"1","author":"Gonzalez-Lorenzo","year":"2024","journal-title":"Cochrane Database Syst. Rev."},{"key":"2025063011311691900_BST-2023-1085C70","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pharmthera.2005.05.002","article-title":"FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors","volume":"108","author":"Chiba","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"2025063011311691900_BST-2023-1085C71","doi-asserted-by":"crossref","DOI":"10.3390\/cells11132058","article-title":"Sphingosine-1-phosphate (S1P) and S1P signaling pathway modulators, from current insights to future perspectives","volume":"11","author":"Bravo","year":"2022","journal-title":"Cells"},{"key":"2025063011311691900_BST-2023-1085C72","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40268-023-00434-6","article-title":"The benefits and risks of switching from fingolimod to siponimod for the treatment of relapsing-remitting and secondary progressive multiple sclerosis","volume":"23","author":"Vali\u0161","year":"2023","journal-title":"Drugs R. D"},{"key":"2025063011311691900_BST-2023-1085C73","doi-asserted-by":"crossref","first-page":"105670","DOI":"10.1016\/j.msard.2024.105670","article-title":"Long-term neuroprotective effects of natalizumab and fingolimod in multiple sclerosis: evidence from real-world clinical data","volume":"87","author":"Noteboom","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"2025063011311691900_BST-2023-1085C74","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2990.2007.00805.x","article-title":"Remyelination can be extensive in multiple sclerosis despite a long disease course","volume":"33","author":"Patani","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"2025063011311691900_BST-2023-1085C75","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3233\/BPL-160042","article-title":"Imaging central nervous system demyelination and remyelination by positron-emission tomography","volume":"2","author":"Bodini","year":"2016","journal-title":"Brain Plast."},{"key":"2025063011311691900_BST-2023-1085C76","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.24620","article-title":"Dynamic imaging of individual remyelination profiles in multiple sclerosis","volume":"79","author":"Bodini","year":"2016","journal-title":"Ann Neurol"},{"key":"2025063011311691900_BST-2023-1085C77","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41582-023-00801-6","article-title":"Inflammation in multiple sclerosis: consequences for remyelination and disease progression","volume":"19","author":"Klotz","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"2025063011311691900_BST-2023-1085C78","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.neuron.2022.09.023","article-title":"CNS remyelination and inflammation: from basic mechanisms to therapeutic opportunities","volume":"110","author":"Franklin","year":"2022","journal-title":"Neuron"},{"key":"2025063011311691900_BST-2023-1085C79","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.604865","article-title":"Myelin repair: from animal models to humans","volume":"15","author":"Cayre","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"2025063011311691900_BST-2023-1085C80","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3390\/brainsci3031109","article-title":"Astrocyte regulation of CNS inflammation and remyelination","volume":"3","author":"Claycomb","year":"2013","journal-title":"Brain Sci."},{"key":"2025063011311691900_BST-2023-1085C81","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00401-020-02189-9","article-title":"Lesion stage-dependent causes for impaired remyelination in MS","volume":"140","author":"He\u00df","year":"2020","journal-title":"Acta Neuropathol."},{"key":"2025063011311691900_BST-2023-1085C82","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/jnen\/nlx023","article-title":"Cortical remyelination is heterogeneous in multiple sclerosis","volume":"76","author":"Strijbis","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2025063011311691900_BST-2023-1085C83","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/brain\/awac334","article-title":"Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration","volume":"146","author":"Tonietto","year":"2023","journal-title":"Brain (Bacau)"},{"key":"2025063011311691900_BST-2023-1085C84","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40263-015-0297-0","article-title":"The direct effects of fingolimod in the central nervous system: implications for relapsing multiple sclerosis","volume":"30","author":"Hunter","year":"2016","journal-title":"CNS Drugs"},{"key":"2025063011311691900_BST-2023-1085C85","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00807","article-title":"Sphingosine 1-phosphate receptors and metabolic enzymes as druggable targets for brain diseases","volume":"10","author":"Grassi","year":"2019","journal-title":"Front. Pharmacol."},{"key":"2025063011311691900_BST-2023-1085C86","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204509119","article-title":"Siponimod ameliorates metabolic oligodendrocyte injury via the sphingosine-1 phosphate receptor 5","volume":"119","author":"Behrangi","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2025063011311691900_BST-2023-1085C87","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-87825-8","article-title":"Siponimod supports remyelination in the non-supportive environment","volume":"15","author":"Kr\u00fcger","year":"2025","journal-title":"Sci. Rep."},{"key":"2025063011311691900_BST-2023-1085C88","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301557RR","article-title":"The sphingosine-1-phosphate receptor 1 modulator ponesimod repairs cuprizone-induced demyelination and induces oligodendrocyte differentiation","volume":"38","author":"Willems","year":"2024","journal-title":"FASEB J."},{"key":"2025063011311691900_BST-2023-1085C89","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1002\/glia.24074","article-title":"Sphingosine kinase 2 is essential for remyelination following cuprizone intoxication","volume":"69","author":"Song","year":"2021","journal-title":"Glia"},{"key":"2025063011311691900_BST-2023-1085C90","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41593-024-01642-2","article-title":"Dynamics of mature myelin","volume":"27","author":"Osso","year":"2024","journal-title":"Nat. Neurosci."},{"key":"2025063011311691900_BST-2023-1085C91","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcdb.2020.09.009","article-title":"Revisiting remyelination: towards a consensus on the regeneration of CNS myelin","volume":"116","author":"Franklin","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"2025063011311691900_BST-2023-1085C92","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrn2480","article-title":"Remyelination in the CNS: from biology to therapy","volume":"9","author":"Franklin","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"2025063011311691900_BST-2023-1085C93","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrn.2017.136","article-title":"Regenerating CNS myelin \u2014 from mechanisms to experimental medicines","volume":"18","author":"Franklin","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"2025063011311691900_BST-2023-1085C94","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00018-020-03586-9","article-title":"Macroglial diversity: white and grey areas and relevance to remyelination","volume":"78","author":"Werkman","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"2025063011311691900_BST-2023-1085C95","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/glia.23607","article-title":"Diversity in the oligodendrocyte lineage: plasticity or heterogeneity?","volume":"67","author":"Foerster","year":"2019","journal-title":"Glia"},{"key":"2025063011311691900_BST-2023-1085C96","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.neuron.2018.12.020","article-title":"Oligodendrocyte progenitor cells become regionally diverse and heterogeneous with age","volume":"101","author":"Spitzer","year":"2019","journal-title":"Neuron"},{"key":"2025063011311691900_BST-2023-1085C97","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/glia.23305","article-title":"Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination","volume":"66","author":"Coppolino","year":"2018","journal-title":"Glia"},{"key":"2025063011311691900_BST-2023-1085C98","doi-asserted-by":"crossref","first-page":"10593","DOI":"10.1074\/jbc.M110.162867","article-title":"Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation","volume":"286","author":"Fumagalli","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2025063011311691900_BST-2023-1085C99","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s12035-018-1146-1","article-title":"G-protein-coupled receptor Gpr17 expression in two multiple sclerosis remyelination models","volume":"56","author":"Nyamoya","year":"2019","journal-title":"Mol Neurobiol"},{"key":"2025063011311691900_BST-2023-1085C100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26685\/urncst.396","article-title":"G protein-coupled receptor 17 inhibition as a prospective treatment for multiple sclerosis: a research protocol","volume":"6","author":"Rehill","year":"2022","journal-title":"URNCST Journal"},{"key":"2025063011311691900_BST-2023-1085C101","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.stem.2010.04.002","article-title":"CNS-resident glial progenitor\/stem cells produce schwann cells as well as oligodendrocytes during repair of CNS demyelination","volume":"6","author":"Zawadzka","year":"2010","journal-title":"Cell Stem Cell"},{"key":"2025063011311691900_BST-2023-1085C102","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1523\/JNEUROSCI.2409-16.2017","article-title":"Myelinogenic plasticity of oligodendrocyte precursor cells following spinal cord contusion injury","volume":"37","author":"Assinck","year":"2017","journal-title":"J. Neurosci."},{"key":"2025063011311691900_BST-2023-1085C103","doi-asserted-by":"crossref","first-page":"E11807","DOI":"10.1073\/pnas.1808064115","article-title":"The adult oligodendrocyte can participate in remyelination","volume":"115","author":"Duncan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2025063011311691900_BST-2023-1085C104","article-title":"In vivo imaging reveals mature oligodendrocyte division in adult zebrafish","volume":"10","author":"Zou","year":"2021","journal-title":"Cell Regen. (Lond)."},{"key":"2025063011311691900_BST-2023-1085C105","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41593-020-0637-3","article-title":"Motor learning promotes remyelination via new and surviving oligodendrocytes","volume":"23","author":"Bacmeister","year":"2020","journal-title":"Nat. Neurosci."},{"key":"2025063011311691900_BST-2023-1085C106","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56621","article-title":"Remyelination alters the pattern of myelin in the cerebral cortex","volume":"9","author":"Orthmann-Murphy","year":"2020","journal-title":"Elife"},{"key":"2025063011311691900_BST-2023-1085C107","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-018-0842-3","article-title":"Dynamics of oligodendrocyte generation in multiple sclerosis","volume":"566","author":"Yeung","year":"2019","journal-title":"Nature"},{"key":"2025063011311691900_BST-2023-1085C108","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.stem.2020.03.017","article-title":"Problems and pitfalls of identifying remyelination in multiple sclerosis","volume":"26","author":"Neumann","year":"2020","journal-title":"Cell Stem Cell"},{"key":"2025063011311691900_BST-2023-1085C109","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1474-4422(20)30140-X","article-title":"Remyelination in multiple sclerosis: from basic science to clinical translation","volume":"19","author":"Lubetzki","year":"2020","journal-title":"Lancet Neurol."},{"key":"2025063011311691900_BST-2023-1085C110","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.celrep.2020.01.010","article-title":"Microglia heterogeneity in the single-cell era","volume":"30","author":"Masuda","year":"2020","journal-title":"Cell Rep."},{"key":"2025063011311691900_BST-2023-1085C111","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","article-title":"Microglia states and nomenclature: a field at its crossroads","volume":"110","author":"Paolicelli","year":"2022","journal-title":"Neuron"},{"key":"2025063011311691900_BST-2023-1085C112","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/jnc.12705","article-title":"Macrophages and CNS remyelination","volume":"130","author":"Miron","year":"2014","journal-title":"J. Neurochem."},{"key":"2025063011311691900_BST-2023-1085C113","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/glia.24111","article-title":"Monocytes in central nervous system remyelination","volume":"70","author":"Forbes","year":"2022","journal-title":"Glia"},{"key":"2025063011311691900_BST-2023-1085C114","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41582-019-0184-2","article-title":"The pro-remyelination properties of microglia in the central nervous system","volume":"15","author":"Lloyd","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"2025063011311691900_BST-2023-1085C115","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nn.3469","article-title":"M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination","volume":"16","author":"Miron","year":"2013","journal-title":"Nat. Neurosci."},{"key":"2025063011311691900_BST-2023-1085C116","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040945","article-title":"Delayed demyelination and impaired remyelination in aged mice in the cuprizone model","volume":"9","author":"Gingele","year":"2020","journal-title":"Cells"},{"key":"2025063011311691900_BST-2023-1085C117","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3390\/cimb44030083","article-title":"The Selective Agonist for Sphingosine-1-Phosphate Receptors Siponimod Increases the Expression Level of NR4A Genes in Microglia Cell Line","volume":"44","author":"Montarolo","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"2025063011311691900_BST-2023-1085C118","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1007\/s11064-018-2701-x","article-title":"Human remyelination promoting antibody stimulates astrocytes proliferation through modulation of the sphingolipid rheostat in primary rat mixed glial cultures","volume":"44","author":"Grassi","year":"2019","journal-title":"Neurochem Res"},{"key":"2025063011311691900_BST-2023-1085C119","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1189\/jlb.3RI1116-494R","article-title":"Microglia-driven regulation of oligodendrocyte lineage cells, myelination, and remyelination","volume":"101","author":"Miron","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"2025063011311691900_BST-2023-1085C120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-022-05534-y","article-title":"Microglia regulate central nervous system myelin growth and integrity","volume":"613","author":"McNamara","year":"2023","journal-title":"Nature"},{"key":"2025063011311691900_BST-2023-1085C121","doi-asserted-by":"crossref","first-page":"113574","DOI":"10.1016\/j.celrep.2023.113574","article-title":"Microglia promote remyelination independent of their role in clearing myelin debris","volume":"42","author":"Baaklini","year":"2023","journal-title":"Cell Rep."},{"key":"2025063011311691900_BST-2023-1085C122","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01734-3","article-title":"Involvement of Wnt7a in the role of M2c microglia in neural stem cell oligodendrogenesis","volume":"17","author":"Mecha","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"2025063011311691900_BST-2023-1085C123","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/glia.23333","article-title":"The extracellular matrix: focus on oligodendrocyte biology and targeting CSPGs for remyelination therapies","volume":"66","author":"Pu","year":"2018","journal-title":"Glia"},{"key":"2025063011311691900_BST-2023-1085C124","doi-asserted-by":"crossref","first-page":"R326","DOI":"10.1016\/j.cub.2021.01.056","article-title":"Astrocytes","volume":"31","author":"Hasel","year":"2021","journal-title":"Curr. Biol."},{"key":"2025063011311691900_BST-2023-1085C125","doi-asserted-by":"crossref","DOI":"10.3390\/cells13110921","article-title":"Neurodegenerative diseases: unraveling the heterogeneity of astrocytes","volume":"13","author":"Santiago-Balmaseda","year":"2024","journal-title":"Cells"},{"key":"2025063011311691900_BST-2023-1085C126","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.tins.2020.05.006","article-title":"The role of astrocytes in remyelination","volume":"43","author":"Rawji","year":"2020","journal-title":"Trends Neurosci."},{"key":"2025063011311691900_BST-2023-1085C127","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jnc.16011","article-title":"Microglia-derived extracellular vesicles in homeostasis and demyelination\/remyelination processes","volume":"168","author":"Wies Mancini","year":"2024","journal-title":"J. Neurochem."},{"key":"2025063011311691900_BST-2023-1085C128","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1046\/j.1365-2990.2003.00491.x","article-title":"Astrocyte characterization in the multiple sclerosis glial scar","volume":"29","author":"Holley","year":"2003","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"2025063011311691900_BST-2023-1085C129","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/glia.24148","article-title":"The roles of microglia and astrocytes in phagocytosis and myelination: Insights from the cuprizone model of multiple sclerosis","volume":"70","author":"Sen","year":"2022","journal-title":"Glia"},{"key":"2025063011311691900_BST-2023-1085C130","doi-asserted-by":"crossref","DOI":"10.3390\/cells13121024","article-title":"Oligodendrocyte progenitors in glial scar: a bet on remyelination","volume":"13","author":"Marangon","year":"2024","journal-title":"Cells"},{"key":"2025063011311691900_BST-2023-1085C131","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41582-023-00822-1","article-title":"Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration","volume":"19","author":"Patani","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"2025063011311691900_BST-2023-1085C132","doi-asserted-by":"crossref","first-page":"102261","DOI":"10.1016\/j.coph.2022.102261","article-title":"Recent insights into astrocytes as therapeutic targets for demyelinating diseases","volume":"65","author":"Gorter","year":"2022","journal-title":"Curr. Opin. Pharmacol."},{"key":"2025063011311691900_BST-2023-1085C133","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1073\/pnas.1721732115","article-title":"Increase in chemokine CXCL1 by ER\u03b2 ligand treatment is a key mediator in promoting axon myelination","volume":"115","author":"Karim","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2025063011311691900_BST-2023-1085C134","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/dna.2019.5182","article-title":"CXCR2 signaling and remyelination in preclinical models of demyelination","volume":"39","author":"Skinner","year":"2020","journal-title":"DNA Cell Biol."},{"key":"2025063011311691900_BST-2023-1085C135","doi-asserted-by":"crossref","first-page":"12174","DOI":"10.1523\/JNEUROSCI.2289-06.2006","article-title":"Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation","volume":"26","author":"Zhang","year":"2006","journal-title":"J. Neurosci."},{"key":"2025063011311691900_BST-2023-1085C136","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/685317","article-title":"Local overexpression of interleukin-11 in the central nervous system limits demyelination and enhances remyelination","volume":"2013","author":"Maheshwari","year":"2013","journal-title":"Mediators Inflamm"},{"key":"2025063011311691900_BST-2023-1085C137","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.nbd.2016.03.023","article-title":"Activation of oligodendroglial Stat3 is required for efficient remyelination","volume":"91","author":"Steelman","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"2025063011311691900_BST-2023-1085C138","doi-asserted-by":"crossref","first-page":"106808","DOI":"10.1016\/j.intimp.2020.106808","article-title":"The immunoregulatory and neuroprotective effects of human adipose derived stem cells overexpressing IL-11 and IL-13 in the experimental autoimmune encephalomyelitis mice","volume":"87","author":"Azimzadeh","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"2025063011311691900_BST-2023-1085C139","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-015-0393-6","article-title":"Fingolimod induces neuroprotective factors in human astrocytes","volume":"12","author":"Hoffmann","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"2025063011311691900_BST-2023-1085C140","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/jnr.24509","article-title":"Possible regenerative effects of fingolimod (FTY720) in multiple sclerosis disease: an overview on remyelination process","volume":"98","author":"Yazdi","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"2025063011311691900_BST-2023-1085C141","doi-asserted-by":"crossref","first-page":"121","DOI":"10.33588\/rn.5903.2013556","article-title":"Central effects of fingolimod","volume":"59","author":"Cruz","year":"2014","journal-title":"Rev. Neurol."},{"key":"2025063011311691900_BST-2023-1085C142","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jns.2008.06.031","article-title":"Central nervous system-directed effects of FTY720 (fingolimod)","volume":"274","author":"Miron","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"2025063011311691900_BST-2023-1085C143","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12030594","article-title":"The effects of the S1P receptor agonist fingolimod (FTY720) on central and peripheral myelin in twitcher mice","volume":"12","author":"B\u00e9chet","year":"2024","journal-title":"Biomedicines"},{"key":"2025063011311691900_BST-2023-1085C144","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-8-76","article-title":"Fingolimod modulates microglial activation to augment markers of remyelination","volume":"8","author":"Jackson","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"2025063011311691900_BST-2023-1085C145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/brain\/aws262","article-title":"Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination","volume":"136","author":"Skripuletz","year":"2013","journal-title":"Brain (Bacau)"},{"key":"2025063011311691900_BST-2023-1085C146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002605","article-title":"Oligodendroglial myelination requires astrocyte-derived lipids","volume":"15","author":"Camargo","year":"2017","journal-title":"Plos Biol."},{"key":"2025063011311691900_BST-2023-1085C147","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s11064-023-03859-2","article-title":"Identification of the lipid antigens recognized by rHIgM22, a remyelination-promoting antibody","volume":"48","author":"Grassi","year":"2023","journal-title":"Neurochem. Res."},{"key":"2025063011311691900_BST-2023-1085C148","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.97.12.6820","article-title":"Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis","volume":"97","author":"Warrington","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2025063011311691900_BST-2023-1085C149","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jnr.21217","article-title":"A recombinant human IgM promotes myelin repair after a single, very low dose","volume":"85","author":"Warrington","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"2025063011311691900_BST-2023-1085C150","first-page":"241","article-title":"Human antibodies accelerate the rate of remyelination following in mice","volume":"37","author":"Bieber","year":"2002","journal-title":"Mult. Scler."},{"key":"2025063011311691900_BST-2023-1085C151","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nbd.2017.05.015","article-title":"rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination","volume":"105","author":"Mullin","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"2025063011311691900_BST-2023-1085C152","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2018.05.013","article-title":"The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination","volume":"1694","author":"Cui","year":"2018","journal-title":"Brain Res"},{"key":"2025063011311691900_BST-2023-1085C153","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1044-7431(02)00018-0","article-title":"Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair","volume":"22","author":"Sold\u00e1n","year":"2003","journal-title":"Molecular and Cellular Neuroscience"},{"key":"2025063011311691900_BST-2023-1085C154","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055149","article-title":"PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation","volume":"8","author":"Watzlawik","year":"2013","journal-title":"Plos One"},{"key":"2025063011311691900_BST-2023-1085C155","article-title":"A double-blind, placebo-controlled, single-ascending-dose intravenous infusion study of rHIgM22 in subjects with multiple sclerosis immediately following A relapse","volume":"8","author":"Greenberg","year":"2022","journal-title":"Transl Clin"}],"container-title":["Biochemical Society Transactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/53\/03\/653\/974605\/bst-2023-1085.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/53\/03\/653\/974605\/bst-2023-1085.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T15:31:54Z","timestamp":1751297514000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article\/53\/03\/653\/236218\/How-do-different-cell-populations-orchestrate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":155,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2025,6,23]]},"published-print":{"date-parts":[[2025,6,30]]}},"URL":"https:\/\/doi.org\/10.1042\/bst20231085","relation":{},"ISSN":["0300-5127","1470-8752"],"issn-type":[{"value":"0300-5127","type":"print"},{"value":"1470-8752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]}}}